Min/+ mice spontaneously develop multiple intestinal adenomas along the length of the small intestine and colon. Currently little is known about the role of the immune system in regulating intestinal tumorigenesis in these animals. ) mice on the same genetic background revealed decreased tumour multiplicity in the absence of both αβ and γδ T-cells. This study demonstrates that altered T-cell subsets play important roles in promoting tumorigenesis in Apc Min/+ mice and forms the basis for future mechanistic studies.
Introduction

C57BL/6J Apc
Min/+ mice carry a heterozygous point mutation in the Adenomatous polyposis coli (Apc) tumour suppressor gene resulting in a truncated protein lacking C-terminal domains (1, 2) . Apc is a negative regulator of the Wnt signalling pathway with loss of Apc function leading to dysregulated transcription of Wnt/β-catenin target genes (3) . Wnt signalling governs cell differentiation and fate in many different tissues including T and B cells (4) . Apc Min/+ mice spontaneously develop intestinal adenomas following loss of the second Apc allele (1, 5) and have been used extensively to identify genetic factors affecting intestinal tumorigenesis, (6,7) such as Mom-1 (8) , Mom-2 (9), Mom-3 (10), Mom-7 (11) and cyclin D1 (12) . Little, however, is currently known about the immune system in the Apc Min/+ mouse and its role in intestinal tumorigenesis. Early studies involving beige (13) and scid mice (14) suggested that NK, T and B cells had no effect on intestinal tumour formation and progression. However, the latter study was performed using scid mice on a C57BL/6 background known to be leaky, allowing some mature lymphocytes to develop, which may have been sufficient for tumour suppression to occur at a level equivalent to C57Bl/6 Apc Min/+ mice. Several studies have suggested roles for the immune system in tumour surveillance including supplementation of diet with Sc-FOS, an indigestible carbohydrate that promotes bacterial growth in the colon (15, 16) and stimulates gut-associated lymphoid tissues, which was associated with reduced colonic tumour multiplicity (17) . This tumour-suppressive effect was subsequently shown to be dependent on the presence of T-cells (18) and IL-15 secretion (19) .
Regulatory (CD4 + CD25 + ) lymphocyte populations have been shown to have differing effects in colon cancer models either by inhibiting anti-tumour surveillance activities or by suppression of inflammation and tumour prevention (20) . In Apc Min/+ mice, addition of CD4 + CD25 + lymphocytes has been shown to reduce tumour multiplicity in the small intestine and colon (21) .
Intraepithelial lymphocytes (IEL) reside between epithelial cells in the small intestine and are thought to contribute to epithelial homeostasis and barrier function (22, 23) . IELs are predominantly CD8 + T-cells (24) with >20% expressing CD4 (25) . Features that distinguish IELs from other T-cell populations are that they contain a greater number of γδ T-cells with the majority of CD8 + IELs expressing a CD8αα homodimer that is virtually absent among circulatory CD8 + T-cells (25) . Based upon differences in phenotype and antigen recognition IELs can be divided into two types; type a αβ IELs are associated with recognition of antigens presented by conventional MHC class I and II molecules and express a CD8αβ heterodimer. Type b CD8αα + αβ and γδ IELs which respond to non-MHC-restricted antigens (26) and are capable of recognising molecules expressed on stressed and transformed epithelial cells (27) (28) (29) , including Rae-1 and H-60 in mice (30) . The immunological function of IELs in general is unknown (23) and conflicting evidence has been obtained for the involvement of γδ T-cells in tumour surveillance (31, 32 Min/+ and wild-type mice and determined the impact of the absence of αβ and γδ T-cell subsets on intestinal tumorigenesis.
Materials and methods
Animals. All animals were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and were bred and housed at the University of Leeds according to institutional and UK Home Office guidelines. All animals were housed in isolators under SPF conditions. Genotyping of mice was performed on genomic DNA (GenElute™, Sigma-Aldrich, Dorset, UK) by ARMS-PCR (34) ). Individual genotypes were confirmed at weaning and again at the time of sacrifice.
Adenoma size and multiplicity. At 120 days of age, animals were sacrificed and the entire small intestine and colon were removed, flushed with PBS and mesentery removed. The small intestine was divided into proximal, middle and distal regions with each being examined in a blinded manner using a dissecting microscope. The largest diameter of each tumour and number of tumours present were recorded for each section. A two-tailed power calculation performed using an average total adenoma count of 51.2 (34) established a test population size of 13 animals being required to detect a 50% difference in adenoma number in the test groups. All adenoma counts were performed in a blinded manner and all initial counts and measurements were confirmed by a second person to confirm accuracy.
Immunohistochemistry. Tissues were fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) and embedded in paraffin wax. Longitudinal sections (6 µm) were cut using a microtome, mounted on SuperFrost Plus microscope slides (BDH) and stained with H&E. Prior to immunohistochemistry, sections were subjected to antigen retrieval (Antigen Unmasking Solution; Vector, Peterborough, UK) and endogenous peroxidase and avidin-biotin activity was blocked using standard protocols. Tissues were then sequentially incubated with a rat anti-mouse CD3 antibody (1:100, Serotec), biotinylated anti-rat antibodies (1:200, Vector), streptavidin-horseradish peroxidase (Vector), diaminobenzidine substrate, and hematoxylin. CD3 + IELs were counted from a minimum of 10 villi per sample along the entire crypt-villus axis. CD3 + IEL counts were performed blinded to animal genotype.
IEL isolation. IELs were isolated from Peyer's patch-excised small intestine (35) . For cytotoxicity assays higher purity preparations of IELs were obtained using a modification of a previously described method (36) . Briefly, the mucosal layer of small intestine was removed by scraping and then dissociated in RPMI-1640 containing 10% (v/v) HI-FCS and 10 mM dithioerythritol. Cell debris was removed using a 0.7-µm cell strainer (BD Biosciences) and single cell suspensions were passed over two glass wool columns (Sigma-Aldrich), after which the cells in the effluent were subjected to Percoll density gradient centrifugation. IELs were harvested at the 40-80% interface and cell number and viability assessed by haemocytometercounting and trypan blue dye exclusion.
Flow cytometry. IELs were stained with a combination of the following monoclonal antibodies: Per-cyP anti-CD3 (145-2C11, BD Biosciences), FITC-anti-TcRγδ (GL3 Fab 2 , Caltag Medsystems), -CD4 (RM4-5, Caltag) and -CD45 (30-F11, Caltag), PE-anti-CD8α (CT-CD8a, Caltag), -Fas (Jo2, BD Biosciences) and -FasL (MFL3, BD Biosciences), APC-anti-Thy-1 (5a-8, Caltag) and -NKG2D (CX5, BD Biosciences) or, biotin-antiTcRαβ (H57-597, Caltag) -CD8β (CT-CD8b, Caltag) or α-NK1.1 (PK136, Caltag) followed by streptavadin-AF633. Background levels of non-specific staining were determined using isotypematched control antibodies. Samples were analysed using FACSCalibur (Becton-Dickinson) and Cellquest software (Becton-Dickinson).
Re-directed cytotoxicity assay. Cellular cytotoxicity was measured using a Live/Dead ® cell assay (Molecular Probes, Leiden, The Netherlands) using the P815 murine mastocytoma cell line (ATCC, Teddington, UK). Briefly, 1x10 4 
Statistical analysis. Statistical testing for differences between
Apc
+/+ and Apc Min/+ mice was performed using non-parametric Mann-Witney U tests. Statistical differences between small intestine regions were calculated using a non-parametric Kruskal-Wallis H test. Statistical testing for differences in adenoma penetrance in Apc Min/+ mice of different genotypes was performed using Chi-square analysis. All statistical analyses were carried out using Statistical Package for the Social Sciences (SPSS, Surrey, UK). Values of p<0.05 were considered statistically significant with different levels of significance indicated as follows; * p<0.05, ** p<0.01 and *** p<0.005. Unless specified, all data are expressed as the mean and standard error of the mean (SEM).
Results
A survey of IEL phenotype was carried out at 40 and 100 days of age prior to and after macroscopic tumour development, respectively. Mice (120-day-old) were used for intestinal phenotype analysis as this time point allowed for maximal macroscopic tumour formation and quantitation prior to the onset of intestinal and extraintestinal complications that result in premature death around 150 days of age in Apc Min/+ mice (1).
Altered IEL populations in Apc
Min/+ mice. Immunohistochemistry and flow cytometry were used to compare the distribution of IELs in Apc +/+ and Apc Min/+ mice. Sections of proximal, middle and distal small intestine from 40-day-old mice were stained with anti-CD3 antibody (Fig. 1A ) and CD3 + IELs were counted in at least 10 complete crypt-villus axes per mouse and from 5 mice per group (Fig. 1B-D (Fig. 1D ). ; p<0.05) (Fig. 2A) . By contrast, the proportion of TCRγδ + IELs expressing the activation-associated antigens, Fas, Thy-1 or FasL were equivalent in Apc +/+ and Apc Min/+ mice at 100 days of age ( Fig. 2A) . Although the number of TcRγδ + IELs expressing NKG2D in Apc +/+ mice was ~2.7-fold higher than in Apc +/+ mice (Fig. 2) (Fig. 3A) . It was also noted that two TcRβ -/-
Apc
Min/+ animals and one TcRδ -/-Apc Min/+ animal failed to develop any adenomas by 120 days (data not shown).
As reported previously (37, 38) , the number of adenomas increased along the proximal-distal axis of the small intestine in Apc Min/+ mice (proximal = 8.31±1.1, middle = 22.1±2.6, distal = 46.31±3.1; p<0.001), which was also seen in Apc Min/+ TcRδ -/-mice (proximal = 6.1±1.1, middle=12.37±4.7, distal=18±4.9; p<0.005) (Fig. 3B) . TcRβ -/-Apc Min/+ mice however had comparable and low numbers of adenomas along the proximal-distal axis of the small intestine (5.49±1.32) (Fig. 3B) (Fig. 3C ). An exception to this was in Apc Min/+ mice lacking γδ IELs where the increase in size of proximal adenomas (2.6±0.13) compared to those in the middle and distal segments did not reach statistical significance (Fig. 3C) . No significant difference was observed in the size of adenomas in the proximal, middle or distal small intestine in Apc Min/+ and Apc Min/+ strains lacking functional αβ or γδ T-cells (Fig. 3C) .
Adenomas in the colon of Apc
Min (Fig. 4) .
Reduced IEL cytotoxicity in Apc
Min/+ mice. Redirected cytolysis assays were used to quantitate IEL cytotoxicity among freshly isolated IELs from 40-and 100-day-old Apc +/+ and Apc Min/+ mice. It was not possible to obtain enough IELs from mice >40 days of age to examine cytotoxicity prior to adenoma development. IELs from 40-day-old Apc Min/+ mice displayed significantly lower levels of killing of P815 target cells at a 10:1 effector:target cell ratio (by 27%, p<0.05) than Apc +/+ IELs (Fig. 5A) . This difference was also observed at lower effector:target cell ratios but was not statistically significant. By contrast, IELs isolated from 100-day-old Apc Min/+ mice (Fig. 5B) showed statistically significant reduced cytotoxicity at all effector:target ratios tested (by 33% at 10:1, p<0.05; by 44% at 5:1, p<0.05; by 53% 
Altered mechanisms of killing among cytotoxic Apc
Min/+ IELs. To investigate the mechanisms of IEL killing redirected cytolysis assays were repeated in the presence of either concanamycin A (CMA) that blocks perforin-granzyme-mediated cytotoxicity or, neutralising anti-FasL antibodies to block Fas-FasL-mediated cytolysis. In the presence of CMA, specific lysis of target cells by Apc +/+ IELs was significantly reduced by 61.5±14.4% with some variation observed between individual animals. (Fig. 6A, p<0.05 ). By contrast, CMA had no significant effect on target cell killing by Apc Min/+ IELs (Fig. 6A) . The reverse was observed using neutralising anti-FasL antibody, which significantly reduced target cell killing by Apc Min/+ IELs by 41.6±9.7% (Fig. 6B, p<0 .05) whereas anti-FasL antibodies had no discernable effect on Apc +/+ IEL killing of the target cells (Fig. 6B) . These findings are consistent with reduced levels of cytotoxicity among IELs in Apc Min/+ mice and differences in the mechanisms by which target cells are killed.
Discussion
The close proximity of IELs to the epithelium in the small intestine makes them ideally suited for immunosurveillance. However, very little is known regarding the effect of IELs and the intestinal immune system in general on tumorigenesis. By surveying IELs in Apc Min/+ mice during adenoma development we have identified modifications in both IEL numbers and cytotoxicity. In addition, we show that the absence of αβ or γδ T-cells significantly reduces adenoma number in the small intestine in the Apc Min/+ model. This suggests that altered T-cell populations and/or function play a role in promoting intestinal tumorigenesis in Apc Min/+ mice, potentially by lack of immune surveillance and or microenvironmental changes.
The absence of similar differences in the distal small intestine may be due to the increased length of villi in the ileum of Apc Min/+ mice (39) . IELs depleted to the greatest extent were type a IELs (TcRαβ + CD8αβ + and TcRαβ + CD4 + ), which are of thymic origin and enter the gut via Peyer's patches (40) . The changes in IEL subset composition occur after tumour initiation (<14 days) and sub-microscopic adenoma formation (~30 days) (5) and may not therefore be a causal factor in the initiation of tumour development. However, it is not known if T cell subsets function normally at this stage. IEL depletion may occur as a consequence of the thymic atrophy and lymphodepletion that occurs in Apc Min/+ mice (41) (42) . The Wnt-β-catenin signalling pathway has a wellcharacterized role in T and B cell development (43, 44) and is necessary for haematopoietic maturation (45 Min/+ mice with intact γδ IEL populations but lacking αβ IELs had significantly fewer tumours than mice that were deficient in γδ IELs. These findings also reinforce the concept of αβ and γδ IELs performing non-overlapping roles within the intestinal mucosa, with αβ IELs being important for immunity (49, 50) and γδ T-cells contributing to epithelial homeostasis (51) (52) (53) . Expression of NK-like molecules on non-MHC restricted γδ T-cells including NKG2D which can recognise ligands on stressed and transformed epithelial cells (27, 28) is consistent with them being better equipped than αβ IELs to influence intestinal epithelial homeostasis.
In summary, this study describes for the first time changes in IEL repertoire and function in Apc
Min/+ mice and shows that the absence of either γδ or αβ IELs impacts upon tumour development.
